Health
The President’s Treatment – American Council on Science and Health
It was announced that President Trump was started on an investigational drug as part of his treatment for COVID-19, Regeneron’s Regn-COV2, a combinational of mo…
The drug is currently in a series of Phase 1 blending into Phase 2 studies. There are no published reports in the literature, and all my information comes from Regeneron’s statements to investors two or three days before it was given to the President.
The drug is a combination of two designer antibodies that attach and “disable” the spike proteins associated specifically with COVID-19, resulting in a reduction of viral load, and at least in “non-human” primates, less lung damage. The underlyin…
-
General24 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News24 hours agoSam Konstas falls cheaply, Jake Weatherald boosts Ashes hopes on day one of Sheffield Shield
-
General20 hours agoNothing to see here *wink wink*
-
General19 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup